Using aminoacyl-tRNA synthetase/suppressor tRNA pairs derived from Methanocaldococcus jannaschii, an Escherichia coli cell-free protein production system affords proteins with site-specifically incorporated unnatural amino acids (UAAs) in high yields through the use of optimized amber suppressor tRNA CUA opt and optimization of reagent concentrations. The efficiency of the cell-free system allows the incorporation of trifluoromethyl-phenylalanine using a polyspecific synthetase evolved previously for p-cyanophenylalanine, and the incorporation of UAAs at two different sites of the same protein without any re-engineering of the E. coli cells used to make the cell-free extract. 
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Introduction
Unnatural amino acids (UAA) positioned in proteins at strategically chosen sites open an exciting new range of possibilities for the study and engineering of proteins and their interactions with other molecules. The most successful approach for site-specific incorporation of UAAs is by genetic encoding, where an amber suppressor tRNA is enzymatically charged with the UAA. With the advent of efficient orthogonal suppressor-tRNA (tRNA CUA )/aminoacyl-tRNA synthetase (RS) systems, this is possible in vivo [1, 2] . It has recently been shown that tRNA CUA /RS systems evolved for in vivo incorporation of UAAs can also be used in cell-free (CF) protein synthesis [3] [4] [5] [6] [7] . In general, modern CF systems produce more protein in a given volume of medium than in vivo systems [8, 9] , which would make them attractive for the production of proteins from expensive UAAs. In addition, optimal reagent concentrations vary among different UAAs, mutants and proteins, highlighting the importance of controlling reaction conditions, which is difficult to achieve in in vivo systems.
Here we report an efficient implementation of tRNA CUA /RS systems for the incorporation of different UAAs in a continuous exchange CF (CECF) system. CECF systems enhance protein yields by the exchange of low-molecular weight compounds across a dialysis membrane [10] . Our system is based on an E. coli CECF system supplied with orthogonal suppressor-tRNA (tRNA CUA ) and aminoacyl-tRNA synthetases (RS) evolved from M. jannaschii [2] . By optimization of the reagent concentrations, the system readily produces proteins with UAAs in yields comparable to those of the wild-type. A recently optimized amber suppressor tRNA CUA opt [11] is found to perform as well or better than the original tRNA CUA [1] . We demonstrate the production of proteins containing UAAs at two different sites, without any need for orthogonal ribosomes [12] or extensively reengineered E. coli strains [13] [14] [15] . Furthermore, we show that a polyspecific RS enzyme [16] that has not previously been used for the incorporation of trifluoromethyl-phenylalanine (tfmF) delivers excellent protein yields at increased RS concentrations. Our system allows protein expression from conventional pET vectors [17] or linear DNA containing the T7 promoter and terminator. By expressing the genes from linear PCR-amplified DNA [18] , the amber mutations and corresponding UAAs are readily introduced at different sites without any cloning step, creating a high-throughput system.
Materials and Methods
Materials
Synthetic oligonucleotides were purchased from GeneWorks (Hindmarsh, SA, Australia) or Integrated DNA Technology, Inc. (Coralville, IA, USA). The sequences of oligonucleotides used are listed in Table S1 (Appendix A). The plasmids pEVOL-pAcF [11] , pEVOL-pAzF [11] , pEVOL-pCNF [11, 16] , pEVOL-CouA [11, 19] , pSup-MjTyrRS-6TRN [20] and pSup-BpaRS-6TRN [20] were obtained from Prof. Peter G. Schultz (Scripps Research Institute, CA, USA). Vent DNA polymerase, restriction enzymes and other enzymes for cloning were from New England Biolabs (Ipswich, MA, USA). The NucleoSpin Extract II kit was obtained from Macherey-Nagel (Düren, Germany). E. coli strains BL21Star (DE3) and BL21 (DE3)/pLysS were from Invitrogen (Carlsbad, CA, USA). ProPur IMAC Mini spin columns were purchased from Nalge Nunc International (USA). L-4-Benzoyl-phenylalanine (Bpa) and L-4-trifluoromethylphenylalanine (tfmF) were purchased from Peptech Corporation (Burlington, MA, USA), and p-acetylphenylalanine (AcF) and p-azidophenylalanine (AzF) were obtained from Mr Ansis Maleckis (University of Latvia). All other standard chemicals necessary for cell-free protein synthesis were as described previously [21] .
tRNA CUA and tRNA CUA opt expression vectors
Total tRNA containing tRNA CUA derived from M. jannaschii [1] or a newly optimized version (tRNA CUA opt ) [11] was purified from E. coli cells containing tRNA CUA or tRNA CUA opt expression vectors. To generate an expression vector for tRNA CUA , the wild-type MjTyrRS gene was excised from the plasmid pSup-MjTyrRS-6TRN (4379 bp) [20] using NdeI and PstI. The resulting vector was treated with T4 DNA polymerase to generate blunt ends and the blunt-ended vector was religated. The resulting plasmid was termed pSUP-6TRN (about 3.2 kb, Cm r ). It contains two sets of three copies of M. jannaschii amber suppressor tyrosyl-tRNA CUA (tRNA CUA ). To generate an expression vector for tRNA CUA opt , the vector pEVOL-pAcF (about 6.1 kb, Cm r ) was digested with BglII and PstI to remove the AcF-RS gene, treated with T4 DNA polymerase to generate blunt ends and re-ligated. The resulting plasmid was termed pKO1474 (about 4 kb, Cm r ). It contains a single copy of the recently optimized M. jannaschii amber suppressor tyrosyl-tRNA CUA (tRNA CUA opt [11] ).
Expression and purification of total tRNA containing suppressor tRNA CUA
Preparations of total tRNA containing suppressor tRNA CUA were obtained from E. coli BL21 Star (DE3) cells harboring the plasmid pSUP-6TRN (for tRNA CUA [20] ) or pKO1474/pEVOL-AcF (for the optimized tRNA CUA opt [11] ). The cells were grown at 37˚ C in 20 L of Z medium [21] (pH 7.3) supplemented with 22.4 mM glucose, 10 mg/L thiamine and 33 mg/L chloramphenicol in a fermenter [21, 22] until A 595 = 3.0. While 15-16 L of this culture were used for subsequent preparation of S30 extracts (see below), the remaining 4-5 L were used for purification of tRNA CUA (or tRNA CUA opt ). 20 g of cells were resuspended in 100 mL of 0.3 M potassium acetate solution (pH 4.8) and the cells were disrupted by being passed twice through a French press at 12,000 psi. Next, an equal volume of water-saturated phenol was added. After vigorous shaking for 1 h at room temperature, the greenish mixture was centrifuged at 18,000 rpm (using a Sorvall SS-34 rotor) for 30 min. The supernatant was subjected to ethanol precipitation. The resulting pellet was air-dried and resuspended in 100 mL of Milli-Q water. It was loaded onto a 2.5 x 8 cm column of Q-Sepharose (Amersham Pharmacia) equilibrated with equilibration buffer (20 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 0.2 M NaCl). The column was washed with 120 mL of equilibration buffer and the total tRNA was eluted with running buffer (20 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 1 M NaCl) at a flow rate of 1.0 mL/min. The eluted tRNA was subjected to ethanol precipitation and resuspended in sterile Milli-Q water to make a 17.5 mg/mL stock solution. Typical yields were about 85 mg of total tRNA. The tRNA concentration was determined by measuring A 260 with a NanoDrop spectrophotometer (Thermo Scientific, USA), assuming A 260 ≈ 40 µg tRNA/mL.
RS enzyme preparations
The M. jannaschii-derived RS enzymes BpyRS, BpaRS, AzF-RS, AcF-RS, HcoRS and CNF-RS for the incorporation of different UAAs [2] were individually produced with His 6 -tags and purified. The wild-type MjTyrRS was overexpressed and purified without a His 6 -tag. Detailed protocols are provided in Appendix A.
Preparation of E. coli S30 extracts
S30 extracts were prepared from the cell cultures grown for suppressor-tRNA preparation (see above) using E. coli BL21 Star (DE3) containing pSup-6TRN (or pKO1474 for the optimized tRNA CUA opt ), using our published standard procedure [21] . Over-expression of T7 RNA polymerase was induced with 1 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) at A 600 = 1.0 and the cells were harvested after a further 2 h incubation at 37 ˚C, A 600 = 3.0 [21, 22] . S30 extracts prepared from E. coli BL21 Star (DE3) without any additional plasmids (but including induction of T7 RNA polymerase) performed equally well for the incorporation of UAAs in CECF experiments.
Cell-free reactions
CECF reactions were carried out as described previously [21] , using either plasmids or PCRamplified DNA as DNA templates, in 0.2 or 0.6 mL reaction mixtures in a dialysis bag suspended in a ten times larger volume of outer buffer. The inner buffer was supplied with purified RS and tRNA, and inner and outer buffers contained the 20 natural amino acids and the UAA (each at 1 mM). Except for the additional presence of tRNA CUA and RS and UAA, the reactions were performed at 30 ˚C in 7 hours or overnight as described previously [21] .
WNVpro mutants Trp53TAG and Tyr132TAG
The WNVpro construct and the mutants with amber stop codons replacing W53 and Y132 were described previously [5, 6] .
WNVpro double-mutant Glu101TAG/Lys104TAG
The double-amber mutant Glu101TAG/Lys104TAG of the WNVpro-K96A gene was prepared in two rounds of PCR, always using Vent DNA polymerase. First, the site-specific mutation was introduced in two separate PCR reactions (50 µL each) with 20-30 ng of pRSET-5b-WNVpro-K96A template [11] . The first reaction used primer 1375 and the reverse primer 2231 (containing the desired mutations) and the second reaction used the forward primer 2230 and primer 1376 (Table S1 ). The PCR products were separately purified by 1.5% agarose gel electrophoresis and extraction from the gel using the NucleoSpin Extract II kit (Macherey-Nagel, Düren, Germany) to remove the residual primers and template plasmid. The gel-purified 5' and 3' DNA fragments from the first round of PCR were mixed together in equimolar ratio to produce the template (20-30 ng) for the second round of PCR (50 µL) using the primer pairs 1375 and 1376 (Table S1 ). The resulting PCR product was digested with NdeI and EcoRI, followed by agarose gel purification and isolation using the NucleoSpin Extract II kit. The isolated WNVpro-K96A gene with the double-amber mutation Glu101TAG/Lys104TAG was cloned into the NdeI-EcoRI sites of the high-copy number pRSET-5b T7-expression vector [23] .
DnaB mutant Phe166TAG
The template DNA of the DnaB Phe166TAG mutant was prepared as linear PCR-amplified DNA without cloning into a vector. Similarly to the double-amber mutant of WNVpro, the template DNA was prepared in two rounds of PCR, using Vent DNA polymerase for all PCR reactions. Starting from plasmid DNA with the E. coli dnaB gene in the vector pETMCSIII [24] . The first round used primer 1375 and the reverse primer 2572 (containing the desired mutation) and the forward primer 2571 and primer 1376 in separate reactions. Following gel-purification and mixing in equimolar ratio as described above, the second round of PCR appended the T7 promoter and terminator sequences in two separate PCR reactions (50 µL each) using the primer pairs 1131 and 1134, and 1132 and 1133, respectively (Table S1) , with a mixture of 20-30 ng of purified PCR products from the first round. The two PCR products were mixed in an approximately equimolar ratio and the residual primers removed using the NucleoSpin Extract II kit. Following denaturation at 95 ˚C (5 min) and reannealing at room temperature (5 min), this generated DNA with complementary single-stranded 8-nt overhangs suitable for cyclization by the intrinsic ligase activity of the cell extract [18, 22] . The reannealed DNA solution was used as the template for subsequent cell-free protein synthesis at a concentration of about 10 µg DNA per mL of reaction mixture.
Results
CECF reactions
Our CECF system is based on the system described by Kigawa et al. [10] , which we modified in several aspects [21] , most importantly by using an S30 extract from the OmpT protease deficient E. coli strain BL21 Star (DE3) and by inducing the cells grown to produce the S30 extract with IPTG at A 600 = 1 to produce T7 RNA polymerase, obviating the need for additional polymerase during the CF reactions. In addition, tRNA CUA derived from M. jannaschii [1] or a newly optimized version (tRNA CUA opt ) [11] was provided together with the natural tRNAs by supplying a total tRNA mixture purified from E. coli cells containing tRNA CUA or tRNA CUA opt expression vectors, and the M. jannaschii-derived RS enzymes for the incorporation of different UAAs [2] were provided as purified proteins following expression with a His 6 -tag. Fig. 1 shows that the protein yields in CECF synthesis with UAAs depended on the sequence context of the amber stop codon. Total tRNA containing the tRNA CUA opt optimized previously for in vivo expression [11] invariably performed as well or better than the original tRNA CUA [1] for a range of different proteins ( Fig. 1 and unpublished results) . 
Comparison of tRNA CUA and tRNA CUA opt
Incorporation of UAAs at two different sites in the same protein
Using tRNA CUA opt , we tested the possibility of incorporating two UAAs at two different sites, using the double mutant WNVpro with amber codons at positions 101 and 104. Fig. 2 shows that CECF reactions with tRNA CUA opt delivered good yields with a range of different UAAs. As might be expected for different RS activities, different UAAs were incorporated with different efficiencies under otherwise similar conditions. Most notably, for p-acetyl-phenylalanine (AcF), bipyridyl-phenylalanine (Bpy) and Hco, the expression yields approached that of the wild-type protein without UAAs (Fig. 2) . Fig. 2 . Incorporation of UAAs into WNVpro at two different sites. The codons for Glu101 and Lys104 were replaced by amber codons. In all experiments, the concentration of total tRNA containing tRNA CUA opt was 175 µg/mL and the UAA was present at 1 mM. Wild-type and mutant MjTyrRS were supplied as purified proteins. Except for the wild-type MjTyrRS, all RS had an Nterminal His 6 -tag. The lanes are labeled with the UAA used. wt: control without amber codons. Tyr: double amber mutant made using 1.1 mg/mL MjTyrRS; Bpa: 1.1 mg/mL BpaRS; AzF: 1.1 mg/mL AzF-RS; 1.1 mg/mL AcF-RS; Bpy: 1.4 mg/mL BpyRS; 0.87 mg/mL HcoRS. The proteins were purified over a Ni-NTA column. The bands of the His-tagged RS enzymes were used as internal references for estimating the yield of the WNVpro mutants. The SDS-PAGE (15%) gel was stained with Coomassie blue for visualization.3.4. Incorporating trifluoromethyl-phenylalanine using a polyspecific RS. p-benzoyl-phenylalanine (Bpa) and p-azido-phenylalanine (AzF) produced full-length protein in relatively poor yields in the double-mutant of Fig. 2 . In the case of Bpa, expression yields similar to wild-type were obtained by increasing the concentration of tRNA CUA opt , whereas the incorporation of AzF increased only little (Fig. 3A) . This may be attributed to different activities of the respective RS mutants. The yields of WNVpro Glu101Bpa/Lys104Bpa were maximal already at 350 µg/mL (Fig. 3A) . In contrast, using twice as much tRNA CUA opt more than doubled the protein yield when L-4-trifluoromethyl-phenylalanine (tfmF) was incorporated into the Phe166TAG mutant of the E. coli DnaB helicase, using the polyspecific RS enzyme evolved for incorporation of p-cyanophenylalanine (CNF) [16] (Fig. 3B) . To compensate for non-optimal activity with tfmF, the DnaB Phe166tfmF mutant was made in the presence of 2.6-fold more RS enzyme than the WNVpro double-amber mutant. Fig. 4 shows that over 2 mg/mL of DnaB F166tfmF could be produced at high RS and tRNA CUA opt concentrations, with virtually no premature truncation of the protein.
Discussion
Early experiments employed cell-free protein synthesis to demonstrate the possibility of sitespecific incorporation of UAAs into proteins following chemical loading of suppressor tRNA with the UAA [25] . Subsequent development of orthogonal tRNA/RS systems that achieve specific and efficient loading of the suppressor tRNA with the UAA in vivo [1, 2] shifted attention to in vivo systems.
CECF protein synthesis adds distinct advantages to the orthogonal tRNA/RS systems for producing proteins with UAAs. (i) CF synthesis tends to produce significantly higher protein yields per amino acid than in vivo protein expression [8, 9] , which is important for expensive UAAs.
(ii) The possibility to adjust the concentrations of suppressor tRNA and RS is critical for high protein yields, as optimal conditions depend on the sequence context of the amber codons and on the UAA. Adjusting the concentrations of tRNA and RS is much harder to achieve in vivo. For example, the present study demonstrates that the polyspecific CNF-RS [16] can efficiently incorporate tfmF into proteins, if CNF-RS is supplied at increased concentration. Similarly high concentrations of the RS enzyme would be difficult to achieve in vivo without impeding the expression of the target protein. (iii) We showed that two UAAs can readily be incorporated into the same protein without need to impair the activity of RF1, a feat that has previously been achieved only with heavily reengineered systems [13,26.28-30] .
A tRNA CUA /RS system [2] has been implemented earlier in a CF system operating in batch mode [3, 4] . We prefer to use a CECF system because it produces more protein from a smaller reaction volume, reducing the amount of macromolecular reagents (S30 extract, DNA, tRNA and purified RS), which tend to be more costly than the UAAs. In the reported batch mode system, inactivation of the OmpT protease proved deleterious to protein yields [3] . In contrast, we obtain high yields from conventional T7 vectors using the S30 extract from the E. coli ompT strains BL21 Star (DE3) and Rosetta (DE3).
In principle, access to the reaction mixture in CF systems opens the possibility to inactivate the release factor RF1, ensuring that the amber stop codon is only recognized by tRNA CUA . In our hands, however, preliminary experiments using anti-RF1 antibodies [31] or RF1 aptamers [32] gave no improvements over the results shown in Fig. 2 . Notably, however, the performance of the CECF system described here already works reliably with different proteins and UAAs. As expected and demonstrated here, the system allows protein synthesis from linear PCR-amplified DNA [18] also with UAAs, making it easy to generate many different amber mutants as required for systematic mutation studies in a high-throughput approach [33] .
Synthetic protocols Expression constructs of MjTyrRS, BpaRS, AzF-RS, AcF-RS, CNF-RS and HcoRS
The wild-type MjTyrRS gene (about 1.1 kb) was amplified from the plasmid pSup-MjTyrRS-6TRN using the primers 1398 and 1402, and cloned into the NdeI and MluI sites of pETMCSI [1] . The resulting T7-expression vector was termed pKO1377.
The mutant MjTyrRS gene encoding BpaRS was amplified from the plasmid pSupBpaRS-6TRN using the primers 1447 and 1448, and cloned into the NdeI and EcoRI sites of pETMCSIII [1] , resulting in N-terminally His 6 -tagged BpaRS in the T7-expression vector pKO1349.
The gene encoding AzF-RS was amplified from the plasmid pEVOL-AzF [2] using the primers 1398 and 1402, and cloned into the NdeI and MluI sites of pETMCSIII to yield the T7-vector pKO1350.
The gene encoding AcF-RS was amplified from pEVOL-AcF [2] using the primers 1447 and 1448, and cloned into the NdeI and EcoRI sites of pETMCSIII to yield the T7-vector pKO1420.
The CNF-RS gene was PCR-amplified from pEVOL-pCNF [2] using the primers 1398 and 1402, and cloned into the NdeI and MluI sites of pETMCSIII, resulting in the T7-expression vector pCT1537.
The gene encoding HcoRS (CouRS-D8 mutant) was excised with NdeI and EcoRI from pETMCSI-HcoRS [3] , and cloned into the same sites of pETMCSIII to add an N-terminal His 6 -tag, resulting in the T7-vector pETMCSIII-HcoRS. The enzyme corresponds to the CouRS-D8 mutant described by Wang et al. [4] .
Only the enzymes BpaRS, AzF-RS and HcoRS contained the D286R mutation that enhances the recognition of the tRNA by the RS enzymes [5] .
Expression and purification of RS enzymes
The expression and purification of N-terminally His 6 -tagged BpyRS was described previously [6] .
